Showing results (111-120 of 178) with videos related to
Sort By:
Pageof 18
European Journal of Pharmacology|July 15, 1979
Digitalis drugs and vulnerability to ventricular fibrillationW W Brooks, R L Verrier, B LownThe American Journal of Cardiology|November 1, 1975
Vulnerability to ventricular fibrillation during acute coronary arterial occlusion and releaseP J Axelrod, R L Verrier, B LownCirculation Research|May 1, 1979
Central serotonergic agents raise the repetitive extrasystole threshold of the vulnerable period of the canine ventricular myocardiumC M Blatt, S H Rabinowitz, B LownCardiovascular Research|May 1, 1980
Protective effect of verapamil on vulnerability to ventricular fibrillation during myocardial ischaemia and reperfusionW W Brooks, R L Verrier, B LownCardiovascular Research|March 1, 1978
Protective effect of the vagotonic action of morphine sulphate on ventricular vulnerabilityR A EdSilva, R L Verrier, B LownThe American Journal of Cardiology|August 1, 1982
Effects of sulfinpyrazone on ventricular vulnerability in the normal and the ischemic heartE A Raeder, R L Verrier, B LownCirculation Research|June 1, 1977
Effect of stellectomy and vagotomy on ventricular refractoriness in dogsP J Schwartz, R L Verrier, B LownJournal of the American College of Cardiology|June 1, 1983
Intrinsic sympathomimetic activity and the effects of beta-adrenergic blocking drugs on vulnerability to ventricular fibrillationE A Raeder, R L Verrier, B LownJAMA|April 7, 1975
Programmed "trendscription." A new approach to electrocardiographic monitoringB Lown, R J Matta, H W BesserCirculation|October 1, 1975
The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactionsB S Kolman, R L Verrier, B LownPageof 18